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There is overwhelming evidence that our current high-salt
intake is the major factor increasing blood pressure (BP) and,
thereby, a major cause of cardiovascular disease and kidney
disease worldwide. A reduction in salt intake to the
recommended level of o5–6g/day is very beneficial, and
could prevent millions of deaths each year and make
major savings for healthcare services. Several countries,
e.g., Finland and the UK, have already reduced the amount
of salt being consumed by a combined policy of getting the
food industry to decrease the amount of salt added to foods,
clear labelling on food products, and increasing public
awareness of the harmful effects of salt on health. Many
other developed countries, e.g., Australia, Canada, and the
US, are also stepping up their activities. The major challenge
now is to spread this out worldwide, particularly to
developing countries where E80% of global BP-related
disease burden occurs. In many developing countries, most
of the salt consumed comes from salt added during cooking
or from sauces; therefore, public health campaigns are
needed to encourage consumers to use less salt. A modest
reduction in salt intake across the whole population will
result in major improvements in public health and have huge
economic benefits in all countries around the world. World
Action on Salt and Health (WASH) is a coalition of health
professionals from different countries who know very well
the harm of high BP and has a major role in implementing
changes in their own countries. We welcome nephrologists
to join (http://www.worldactiononsalt.com).
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During evolution, the dietary intake of salt by the human
race and its forebears was o0.25 g/day (0.1 g sodium). The
addition of salt to foods began only about 5000 years ago
when the Chinese discovered that salt could be used to
preserve foods. Salt then became of great economic
importance, as it was possible to preserve foods during the
winter and allowed for the development of settled commu-
nities. Salt was the most taxed and traded commodity in the
world, with the intake reaching a peak around the 1870s.
However, with the invention of the deep freezer and the
refrigerator, salt was no longer required as a preservative. Salt
intake had been declining, but with the recent large increase
in the consumption of highly salted processed foods, salt
intake is now increasing again. The average salt intake in
most countries around the world is E9–12 g/day, with many
Asian countries having mean intakes over 12 g/day.1
Over several million years of evolution, humans have
become genetically programmed to a salt intake of o0.25 g/
day. The recent dietary changes (in evolutionary terms) to the
high-salt intake present a major challenge to the physiological
systems in excreting these large amounts of salt through the
kidneys. The consequence is that the high-salt intake causes a
gradual rise in blood pressure (BP),2,3 thereby increasing the
risk of cardiovascular disease (CVD)4 and renal disease.5–7
Furthermore, a high-salt intake may have direct effects on
stroke,8 left ventricular hypertrophy,9 progression of renal
disease, and proteinuria,5 independent of but additive to the
effect of salt on BP. There is also increasing evidence that salt
intake is indirectly related to obesity through soft drink
consumption,10,11 associated with an increased risk of renal
stones and osteoporosis,12 linked to the severity of asthma,13
and is probably a major cause of stomach cancer.14 The
evidence on these harmful effects of salt has been compre-
hensively examined in several recent review articles.3,15 In this
paper, we provide a brief update on the evidence, particularly
that relating salt to CVD and kidney disease. Additionally, we
provide an update on the activities of reducing salt intake
occurring around the world.
EVIDENCE RELATING SALT TO CVD
CVD is the leading cause of death and disability worldwide.
Raised BP is a major cause of CVD, responsible for 62% of
stroke and 49% of coronary heart disease.16 There is
overwhelming evidence from epidemiological, migration, inter-
vention, treatment, animal, and genetic studies demonstrating
http://www.kidney-international.org m in i rev iew
& 2010 International Society of Nephrology
Received 2 June 2010; accepted 9 June 2010; published online
18 August 2010
Correspondence: Feng J. He, Centre for Environmental and Preventive
Medicine, Wolfson Institute of Preventive Medicine, Barts and The London
School of Medicine & Dentistry, Queen Mary University of London,
Charterhouse Square, London EC1M 6BQ, UK. E-mail: f.he@qmul.ac.uk
Kidney International (2010) 78, 745–753 745
that dietary salt is the major cause of raised BP and is largely
responsible for the rise in BP with age, and that a reduction
in salt intake lowers BP, thereby reducing BP-related
diseases.3 On the basis of the falls in BP from a meta-
analysis of randomized salt reduction trials,17 it was
estimated that a reduction of 6 g/day in salt intake would
reduce stroke by 24% and coronary heart disease by 18%.
This would prevent E35,000 stroke and coronary heart
disease deaths a year in the UK18 and E2.5 million deaths
worldwide.
Prospective cohort studies have shown that salt intake was
related to CVD. A recent meta-analysis of 13 cohort studies
with 177,025 participants for a follow-up period between 3.5
and 19 years showed that an increase of 5 g/day in salt intake
was associated with a 23% increase in the risk of stroke and a
14% increase in total CVD.19 After excluding one study
which had serious methodological problems,20 the pooled
analysis showed that a 5 g/day increase in salt intake was
associated with a 17% increase in CVD risk (Figure 1).19
Outcome trials have demonstrated that a reduction in salt
intake results in a decrease in CVD. A follow-up study of
individuals who took part in two large randomized salt
reduction trials, Trial of Hypertension Prevention (TOHP) I
and II, has shown a significant effect of salt reduction on
CVD.4 In the original TOHP trials, over 3000 participants
with an average baseline BP of 127/85 mm Hg were
randomized to a reduced salt group (for 18 months in
TOHP I and 36–48 months in TOHP II) or to a control
group. Compared with the control group, individuals in the
intervention group reduced their salt intake by 25–30% from
an average of E10 g/day. This resulted in a fall in BP of 1.7/
0.9 mm Hg at 18 months (TOHP I) and 1.2/0.7 mm Hg at 36
months (TOHP II). After the original trials were completed,
participants were not given further dietary advice. A follow-
up study at 10–15 years post-trial showed that individuals
who were originally allocated to the reduced-salt group had a
25% lower incidence of cardiovascular events after adjusting
for confounding factors (Figure 2).4 Another outcome trial of
over 2.5 years in elderly Taiwanese veterans (N¼ 1981)
showed that switching from the usual salt (i.e., sodium
chloride) to potassium-enriched salt (49% sodium chloride,
49% potassium chloride, 2% other additives), with a
subsequent reduction of 17% in salt intake and an increase
of 76% in potassium intake, as measured by urinary sodium/
creatinine and potassium/creatinine ratio, resulted in a 40%
decrease in CVD mortality.21
SALT REDUCTION IS ONE OF THE MOST COST-EFFECTIVE
INTERVENTIONS TO REDUCE CVD
Several studies have demonstrated that a reduction in
population salt intake is very cost-effective in both developed
and developing countries.22–28 Murray et al.25 carried out a
global analysis and showed that non-personal health inter-
ventions, including government action to stimulate a
reduction in the salt content of processed foods, were cost-
effective ways to limit CVD and could avert over 21 million
disability-adjusted life years per year worldwide. Studies in
Norway,22 Canada,23 and the US26–28 have all demonstrated
that salt reduction not only saves lives, but also saves money.
For example, a recent study in the US showed that even a very
modest reduction in salt intake of only 10%, which could be
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Figure 1 |Relative risk for stroke and total cardiovascular
disease (CVD) associated with a 5g/day increase in salt
intake. Adapted from Strazzullo et al.19
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Figure 2 |Cumulative incidence of cardiovascular disease
(CVD) by salt intervention group in the Trial of Hypertension
Prevention (TOHP) I and II, adjusted for age, sex, and clinic.
Adapted from Cook et al.4
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easily achieved, as demonstrated in the UK, would prevent
hundreds of thousands of strokes and heart attacks over the
lifetimes of adults aged 40–85 years, who are alive today, and
could save 4$32 billion in medical expenses in the US
alone.28 A larger decrease in salt intake would result in a
larger health improvement and greater cost savings.26 A
modest reduction in salt intake could be as beneficial as
smoking cessation.26
In developing countries, where the healthcare resources
are very limited, a reduction in salt intake is one of the most
cost-effective interventions to reduce CVD. Asaria et al.24
estimated the effects and cost of strategies to reduce salt
intake and to control tobacco use for 23 low- and middle-
income countries that account for 80% of chronic disease
burden in the developing world. They demonstrated that,
over 10 years (from 2006 to 2015), a 15% reduction in
population salt intake could avert 8.5 million CVD deaths
and a 20% reduction in smoking prevalence could avert 3.1
million CVD deaths. The modest reduction in salt intake
could be achieved by a voluntary reduction in the salt content
of processed foods and condiments by manufacturers, plus a
sustained mass-media campaign aimed to encourage dietary
change within households and communities. The cost for
implementing such salt reduction programmes was estimated
to be US$0.09 per person per year. The cost for tobacco
control including both price and non-price measures was
US$0.26 per person per year (Figure 3).24 These figures
clearly suggest that a reduction in salt intake is more or at the
very least just as cost-effective as tobacco control in terms of
reducing CVD on its own, the leading cause of death and
disability worldwide.
EVIDENCE RELATING SALT TO KIDNEY DISEASE
AND KIDNEY STONES
Dietary salt intake increases BP, which, in itself, can cause
kidney disease through hypertensive glomerulosclerosis or
through malignant hypertension. However, more frequently,
salt causes an increase in BP in those who have underlying
kidney diseases. This will accelerate the rate of deterioration
of renal function. There is also increasing evidence from
animal experiments demonstrating that salt may have a direct
effect on kidney function, independent of BP. For instance, in
animal models of renal impairment, a high-salt intake has
been shown to aggravate proteinuria and glomerulosclerosis,
and accelerate progression.29 In both partially nephrecto-
mized, spontaneously hypertensive rats and in the remnant
kidney model of renal failure, salt restriction slowed down
the deterioration of renal impairment to a greater extent than
thiazide diuretics.30
In humans, epidemiological studies have shown a direct
association between salt intake and urinary albumin excre-
tion, independent of BP.31,32 A randomized double-blind trial
in 40 Black hypertensive individuals demonstrated that a
reduction in salt intake from E10 to 5 g/day reduced 24-h
urinary protein by 19% (Po0.01; Figure 4).7 A more recent
double-blind trial in a larger number of individuals including
71 Whites, 69 Blacks, and 29 Asians with mildly raised BP
demonstrated that even a smaller reduction in salt intake, i.e.,
from an average of 9.7 to 6.5 g/day reduced 24-h urinary
albumin excretion significantly in all three ethnic groups.33
Other studies in patients with proteinuria or diabetes showed
that the antiproteinuric effects of an angiotensin-converting
enzyme inhibitor or angiotensin receptor blocker were
abolished by increasing salt intake.6,34 A retrospective analysis
of 57 chronic kidney disease patients, with an average
observation period of 3 years showed that a lower salt intake
reduced proteinuria and slowed down the progression of
renal disease despite a similar BP control between the two
groups on a high-and low-salt intake.5
In patients who are on dialysis, a reduction in salt intake
reduces the amount of fluid that they drink between dialyses.
This particularly applies to hemodialysis patients, where
controlling BP is a major problem. A lower salt intake
decreases weight gain between dialyses and BP is easier to
control.
Salt intake is one of the major dietary determinants of
urinary calcium excretion.12,35 As calcium is the main
component of most urinary stones, salt intake is therefore
an important cause of renal stones. Randomized trials have
demonstrated that a reduction in salt intake reduces calcium
excretion36,37 and reduces reoccurrences of kidney stones.37
WORLDWIDE ACTIONS ON SALT
The World Health Organization (WHO) has set a worldwide
target of a maximum intake of 5 g/day for adults.38 Many
countries have developed their own guidelines and set targets
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for salt intake, e.g., the UK and US guidelines recommend a
salt intake of o6 g/day for adults.39,40 These recommenda-
tions are based on the feasibility of reducing population salt
intake to these levels, but not on the potential maximum
beneficial effects of salt reduction. Therefore, these are viewed
as interim targets. Recently, the UK government’s health
advisory agency, the National Institute for Health and
Clinical Excellence has recommended a reduction in the
population’s salt consumption to 3 g/day by 2025.41
In most developed countries, E80% of salt consumed is
added to foods at the stage of manufacturing,42 and the
consumers have no say over how much salt is added.
Therefore, to achieve a reduction in population salt intake, it
is imperative that the food industry reduces the amount of
salt they add to all foods. Several countries, e.g., Finland, the
UK, have already successfully carried out salt reduction
programmes. Many other developed countries have also
launched national initiatives to reduce salt in foods.
The UK strategy—a model for other countries
The UK is one of the countries leading the way in salt
reduction, and is setting an example for other countries to
follow. In 1996, 22 experts on salt and BP set up an action
group—Consensus Action on Salt and Health (CASH)
following the government’s rejection of the 1994 COMA
(the Committee on Medical Aspects of Food and Nutrition
Policy) panel’s recommendation to reduce salt intake.43,44
CASH has waged a highly successful campaign to persuade
food manufacturers and suppliers to universally and
gradually reduce the salt content of processed foods, educate
the public in becoming more aware of salt in terms of
understanding the impact of salt on their health, and
translate the evidence into public health policy. CASH
persuaded the UK Department of Health to change its stance
on salt, finally resulting in the Chief Medical Officer
endorsing the original recommendations of the COMA
report to reduce salt intake to o6 g/day in adults, and also
ensured that the UK Food Standards Agency (FSA) took on
the task of reducing salt intake.
A strategy to reduce population salt intake was developed
based on the UK’s average salt intake of 9.5 g/day,45 as
measured by 24-h urinary sodium (Table 1). It was estimated
thatE15% of the salt consumed (i.e., 1.4 g) was added either
at the table or during cooking, 5% was naturally present in
the foods (0.5 g), and the rest 80% (7.6 g) was added by the
food industry in processed, canteen, restaurant, and takeaway
foods. To reach the target of 6 g, a total reduction of 3.5 g
(i.e., 40%) was needed. Therefore, the food industry would
need to reduce the amount of salt added to foods from 7.6 to
4.6 g (40% reduction) and the public would need to reduce
the amount of salt they add to foods themselves from 1.4 to
0.9 g (40% reduction).
It was estimated that, in the UK, only E15% of foods
were eaten outside the home, i.e., restaurant, canteen, etc,
and therefore, the main target in the initial phase of salt
reduction focused on foods that were bought in super-
markets. These foods, where salt was added, were split into
more than 80 categories. The FSA set target levels of salt for
each food category that the food industry needed to achieve
within a certain time period.46 The aim was to implement a
step-wise reduction in salt added to foods, i.e., 10–20%
reduction and repeated at 1–2 year intervals. Such reductions
are not detectable by human salt taste receptors47 and cause
no technical or safety issues to the food in question,
therefore, posing no risk to manufacturers and no rejection
from consumers. Recently, the salt targets have been revised
down to ensure that salt intake will reach the target of 6 g/day
by 2012.48
Table 1 | UK strategy for reducing salt
Salt intake
Source g/day
Reduction
needed
Target intake
(g/day)
Table/cooking (15%) 1.4 g 40% reduction 0.9 g
Natural (5%) 0.5 g No reduction 0.5 g
Food industry (80%) 7.6 g 40% reduction 4.6 g
Total: 9.5 g Target: 6.0 g
**
Randomized cross-over
reduced salt diet
Slow
sodium
Placebo
**
** P<0.01 compared with slow sodium period
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Figure 4 |Change in urinary sodium and protein excretion
with a modest reduction in salt intake fromE10 to 5 g/day in
40 hypertensive Blacks.
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The UK salt reduction campaigns started in 2003/2004
and have been successful. The salt content in many food
categories has already been reduced, e.g., a one-third
reduction in the average amount of salt in branded, pre-
packed, sliced bread, and a reduction of over 40% in branded
breakfast cereals.46 Table and cooking salt sales have also been
reduced by E40–50%. The average salt intake, as measured
by 24-h urinary sodium, in the general adult population in
the UK has fallen from 9.5 to 8.6 g/day by May 2008.49 This
change reverses the previous increasing trend for salt intake
and marks the beginning of a substantial reduction in salt
intake, as increasing reductions in salt added to foods are
being made by the food industry. The UK salt reduction
campaigns, which cost just d15 million, led to E6000 fewer
CVD deaths per year, saving the UK economy Ed1.5 billion
per annum.41,50
Clear labelling of the salt content of food is essential for
consumers to choose products with less salt. A front of pack
signpost labelling system51 has been developed in the UK,
which uses a combination of the ‘traffic light’ system, where
there is a colour-coding of green, amber, and red for low,
medium, and high amounts of salt, fat, saturated fat, and
sugar, and the Guideline Daily Amount system where the
amount of salt per portion is expressed as a percentage of the
daily recommended maximum. This type of standardised
label is already being implemented by many supermarkets
and is much preferred by consumers,52 as they can see at a
glance whether a product has a little or a lot of salt. Signpost
labelling has already been shown to have a dramatic effect on
the purchase of foods, particularly of those in the red (high)
category. Despite this, perhaps owing to intense lobbying
from the food industry, the European Parliament has recently
voted against making this scheme mandatory in Europe, and
the shape of the final nutritional labelling legislation is
uncertain.
Finland
Finland was one of the first countries to initiate a systematic
approach to reduce salt intake, in the late 1970s, through
mass-media campaigns, cooperation with the food industry
and implementing salt labelling legislation.53–55 Since the
1980s, many food companies have reduced the salt content of
their food products by replacing conventional table salt with
a sodium-reduced, potassium- and magnesium-enriched
mineral salt known as Pansalt. In the early 1990s, the
Ministry of Trade and Industry, and the Ministry of Social
Affairs and Health set salt labelling legislation for all food
categories, which made a substantial contribution to the salt
intake of the Finnish population. Foods that are high in salt,
e.g., 41.3% in bread, 1.8% in sausages, 1.4% in cheese, are
required to carry a ‘high-salt content’ warning and if a food
product contains a low level of salt, e.g., o0.7% in breads,
1.2% in sausages, 0.7% in cheese, the product is allowed to
display a low-salt label. These different measures have been
very effective and led to a marked reduction in the salt
content of many food categories, e.g., the average salt content
in bread has been decreased by around 20% from E1.5%
to E1.2%.
The salt reduction campaign has resulted in a significant
reduction in the average salt intake of the Finnish popula-
tion53,55 fromE14 g/day in 1972 too9 g/day in 2002.53 The
reduction in salt intake was accompanied by a fall of over
10 mm Hg in both systolic and diastolic BP, a pronounced
decrease of 75–80% in both stroke and coronary heart disease
mortality, and a remarkable increase of 5–6 years in life
expectancy.53 The reduction in salt intake was a major
contributory factor for these results, particularly the fall in
BP as both body mass index and alcohol consumption had
increased during that period. An increase in potassium intake
via the use of reduced-sodium, potassium- and magnesium-
enriched salt, an increased consumption of fruit and
vegetables, a reduction in fat intake, and a decrease in
smoking rate in men also played an important part in the fall
in CVD.
Japan
In the late 1950s, deaths from stroke in Japan were among the
highest in the world, and salt intake was also very high. It was
found that the number of stroke in different parts of Japan
was directly related to the amount of salt consumed. The
Japanese government initiated a campaign to reduce salt
intake. Over the following decade, the national salt intake was
reduced from an average of 13.5 to 12.1 g/day and in the
north, salt intake fell dramatically from 18 to 14 g/day.
Paralleling this reduction in salt intake, there were falls in BP
both in adults and children, and an 80% reduction in stroke
mortality56 despite large increases in fat intake, cigarette
smoking, alcohol consumption, and obesity. It would appear
that the Western influence, which was rapidly overtaking
Japan at that time, had little effect on BP, provided salt intake
was reduced. Overall the reduction in salt intake appeared to
be associated with the fall in deaths from stroke.
The US
In the US, there has been consistent advice to reduce salt
intake too6 g/day since the 1980s. However, little action has
been taken until recently. In 2005, in a petition to the Food
and Drug Administration (FDA), the Center for Science in
the Public Interest called for tougher regulations on salt.57 In
2007, the American Medical Association published a report
calling for a major reduction in the salt content of processed
and restaurant foods.58 The FDA has been urged to cease the
rule that allows salt and its component sodium to be treated
as ‘generally recognized as safe’.57,58 In November 2008,
Michael Bloomberg, the Mayor of New York City, announced
his plan to cut salt levels in processed foods by 20% over
5 years. In January 2010, the National Salt Reduction
Initiative (NSRI), a New York City-led partnership of more
than 40 cities, states, and national health organizations,
unveiled its proposed targets to guide a voluntary reduction
of salt levels in packaged and restaurant foods with an aim of
reducing Americans’ salt intake by 20% over 5 years and 40%
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over 10 years.59 To achieve these reductions, the salt content
of processed and packaged foods will need to decrease by
25% in 5 years and by 50% in 10 years. Similar to the UK
strategy, the US NSRI has developed voluntary 2- and 4-year
interim targets for cutting salt levels in restaurant and
packaged foods.59
More recently, the Institute of Medicine (IOM) released
the report ‘Strategies to Reduce Sodium Intake in the United
States’.60 The report recommends setting mandatory national
standards for the salt levels that food manufacturers,
restaurants, and food service companies can add to their
products in the US, and that all of the relevant health
agencies should be involved in achieving this. The FDA’s role,
as envisioned in the report, will be to set the new standards,
which can be phased in gradually allowing tastes to adjust
over time, although no time scale has been given. Following
IOM’s report, 16 food companies in the US, including food
manufacturers Kraft Foods and HJ Heinz Co, have pledged to
cut the amount of salt in some of their products.
WASH (World Action on Salt and Health)
Following the success of the UK campaign group—CASH,
a world action group—WASH was established in 2005.61
The aim of WASH is to set up similar groups modelled
on CASH suited to each individual country to reduce salt
intake with an appropriate strategy relevant to the needs of
that particular country, and to stimulate actions from the
government and/or department of health, the food industry,
media, and public. WASH is supported by more than 400
members from 81 countries (Figure 5).
WASH works to reduce salt in the diet worldwide by
exerting pressure on multi-national food companies to
reduce the salt content of their products. In 2009, WASH
and the International WASH members conducted a survey of
over 260 branded products from KFC, McDonalds, Kellogg’s,
Nestle, Burger King, and Subway in different countries and
revealed huge variations in salt content in global brands
unrelated to local traditional taste preferences. Not one
product surveyed had the same salt content around the world
and some displayed huge differences from one country to
another. For instance, Kellogg’s All Bran contained 2.15 g of
salt per 100 g in Canada, but only 0.65 g of salt per 100 g just
over the border in the US, less than a third of the Canadian
level.61 This illustrates once again how easy it would be for
the food industry to reduce the amount of salt they add to
foods, particularly as they could do this straightaway to their
branded products. Pressure from campaigns such as this has
resulted in several large multi-national manufacturers pled-
ging to reduce the amount of salt added to foods across the
world. Those already committed to salt reduction worldwide
include Pepsico, Unilever, Kellogg’s, Heinz, Campbell’s, and
Kraft.
WASH members in each country are encouraged to set up
their own country division of WASH to work together on a
local level to lower salt intake specifically in their own
population. For example, in 2007, an Australian Division of
Figure 5 |Action groups on salt reduction around the world. The red dot indicates the location of World Action on Salt and Health
(WASH) members.
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World Action on Salt and Health (AWASH) was established.62
AWASH has launched a national campaign to lower the salt
intake of the Australian population to 6 g/day by 2012. In
March 2010, the Australian government announced salt
targets for bread and breakfast cereals. AWASH is calling on
the government to take urgent action by setting salt target
levels for all processed and take-away foods.
Other developed countries
In Ireland, the Food Safety Authority set a goal to reduce salt
intake in the population to o6 g/day.63 Their strategic
approach includes consumer awareness efforts and actions by
the food industry to lower the salt content of their food
products, where to-date substantial reductions have been
made, e.g., the salt content of breakfast cereals has been
reduced by 11% since 2003.
In Portugal, in view of the high-salt intake and the high
prevalence of stroke, a group of doctors formed an action
group, the Portuguese Action Against Salt and Hypertension
(PAASH). They carried out a pilot study in almost 500 people
and showed that the average salt intake was 11.9 g/day,64
which is twice the recommended level for adults. PAASH
started a mass-media campaign about the harmful con-
sequences of consuming too much salt, along with an
educational campaign directed at food manufacturers, health
authorities, and policy makers. This has led to the Portuguese
Parliament approving a law restricting the salt content of
bread and processed foods.65
In Canada, the first Chair in Hypertension Prevention and
Control was appointed in 2006.66 One of the major aims of
the Chair was to get a reduction in salt intake among the
Canadians. The Chair is supported by a number of health
organizations and scientists. Together, they lobby the
government and the food industry for policies to reduce
the level of salt in foods.15 In October 2007, 17 health
organizations endorsed a national collaborative policy
statement urging reductions in salt in processed and
packaged foods, and the Canadian government established
an expert Sodium Working Group to oversee the imple-
mentation of salt reduction strategies.
Many other developed countries, e.g., New Zealand,
France, Italy, Holland, Belgium, Switzerland, Sweden, Den-
mark, Slovenia, Bulgaria, Croatia, Serbia, and Barbados, are
stepping up their activities to reduce salt intake. The WHO is
starting salt reduction strategies through its regional
directorates.67 The European Union is also following suit
and 11 countries have signed up to make a 16% reduction in
salt intake over 4 years. In February 2010, the Pan American
Health Organization/WHO Regional Expert Group on
cardiovascular disease prevention through dietary salt
reduction68 produced a policy statement outlining the
recommendations for a population-based approach to reduce
dietary salt intake in the Americans. The Policy Statement
provides countries with a roadmap for concerted actions by
governments, non-governmental organizations, and the food
industry. The goal is a gradual and sustained drop in dietary
salt intake to reach national targets or the internationally
recommended target of o5 g/day by 2020.
Developing countries
Approximately 80% of CVD deaths occur in developing
countries (i.e., low- and middle-income countries).69 Salt
intake is very high70 and the healthcare resources are very
constrained in many of these countries. A reduction in salt
intake is probably the most important strategy to combat the
epidemic of CVD in these countries.24
Despite the compelling evidence for a reduction in
population salt intake, little action is happening in develop-
ing countries. Although action groups have been set up in
several countries, e.g., China, Pakistan, Bangladesh, Nepal,
Cuba, Kenya, and Ghana, many developing countries have
not developed dietary guidelines or strategies to reduce salt
intake. It is important that each country determines what its
salt intake is and where the major sources of salt are in the
diet, and then implements a strategic approach to lower salt
intake in the population to the target level. In developing
countries, the major sources of salt consumption are additions
during cooking and in sauces (e.g., soy sauce), spice mixes,
seasonings, pickles, etc. rather than pre-packaged prepared
foods. Public health campaigns are needed to encourage
people to use less salt in their own food preparations.
In many developing countries, more and more processed
foods are being consumed, as their diets are becoming
westernized. The food industry in these countries is poorly
regulated with very little or no food-content labelling,
making informed eating almost impossible. Therefore, many
developing countries need a combined policy of getting the
public to use less salt at home and getting the food industry
to add less salt to foods and to adopt a clear labelling system
such as the signpost labelling system.51 At the same time,
developing countries need to ensure that all imported food
products are low in salt.
Additionally, on behalf of WASH, many members from
both developed and developing nations have supported the
last three World Salt Awareness Weeks held in February each
year. Activities from both developed and developing
countries have ranged from involvement with hypertension
and renal experts, representatives from the health and
education ministries, consumers, the media, and the food
industry. The Salt Awareness Weeks have generated signifi-
cant publicity and helped raise awareness of salt reduction
strategies in many countries.
CONCLUSIONS
There is now overwhelming evidence for a reduction in salt
intake in populations worldwide. Reducing salt from the
current intake of 9–12 g/day to the recommended level of
o5–6 g/day will have major beneficial health effects along with
major cost savings in all countries around the world. Clearly,
the time has now come for action and implementation.
All countries should adopt a coherent and workable
strategy to reduce salt intake. In most developed countries,
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E80% of salt is hidden in foods, i.e., added by the food
industry.42 It is therefore vital to persuade the food industry
to make a gradual and sustained reduction in the amount of
salt they add to foods. Several countries, e.g., Finland, Japan,
and the UK, have successfully carried out salt reduction
programmes and salt intake has already fallen.49,53 Other
countries, e.g., Australia, Canada, the US, are also stepping
up their activities to reduce salt intake by following the UK
model. The global food industry is now poised to reduce the
amount of salt being added to foods and cannot justify the
inequality of reducing salt levels in some countries and
excluding others throughout the world.
In developing countries, where most of the salt consumed
comes from salt either added during cooking or from sauces,
public health campaigns are needed to encourage consumers
to use less salt. As there is an increasing trend in the
consumption of processed foods in many developing
countries, a combined policy of educating the public,
working with the food industry, and clear labelling, is
needed. A modest reduction in population salt intake
worldwide would result in a major improvement in public
health—similar to the provision of clean water and drains in
the late nineteenth century in Europe.
WASH would like to extend its membership to new
members, particularly nephrologists, who are well aware of
the dangers of salt. Joining WASH does not require any time
or financial commitments from the members, but only their
support to salt reduction worldwide. We value information
sharing, feedback, and input from your country and
encourage members to participate in activities such as World
Salt Awareness Week, in particular, by setting up an action
group in your own country. To join, please e-mail WASH
(wash@qmul.ac.uk) or visit the WASH website for more
information (http://www.worldactiononsalt.com).
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